Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.

Kia DA, Noyce AJ, White J, Speed D, Nicolas A; IPDGC collaborators, Burgess S, Lawlor DA, Davey Smith G, Singleton A, Nalls MA, Sofat R, Wood NW.

Ann Neurol. 2018 Jul 16. doi: 10.1002/ana.25294. [Epub ahead of print]

PMID:
30014513
2.

Association between diabetes and subsequent Parkinson disease: A record-linkage cohort study.

De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT.

Neurology. 2018 Jul 10;91(2):e139-e142. doi: 10.1212/WNL.0000000000005771. Epub 2018 Jun 13.

PMID:
29898968
3.

No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation.

Keddie S, Adams A, Kelso ARC, Turner B, Schmierer K, Gnanapavan S, Malaspina A, Giovannoni G, Basnett I, Noyce AJ.

J Neurol. 2018 May;265(5):1089-1095. doi: 10.1007/s00415-018-8801-3. Epub 2018 Mar 3.

4.

Assessing cognitive dysfunction in Parkinson's disease: An online tool to detect visuo-perceptual deficits.

Weil RS, Schwarzkopf DS, Bahrami B, Fleming SM, Jackson BM, Goch TJC, Saygin AP, Miller LE, Pappa K, Pavisic I, Schade RN, Noyce AJ, Crutch SJ, O'Keeffe AG, Schrag AE, Morris HR.

Mov Disord. 2018 Apr;33(4):544-553. doi: 10.1002/mds.27311. Epub 2018 Feb 23.

5.

Dopamine reuptake transporter-single-photon emission computed tomography and transcranial sonography as imaging markers of prediagnostic Parkinson's disease.

Noyce AJ, Dickson J, Rees RN, Bestwick JP, Isaias IU, Politis M, Giovannoni G, Warner TT, Lees AJ, Schrag A.

Mov Disord. 2018 Mar;33(3):478-482. doi: 10.1002/mds.27282. Epub 2018 Jan 30.

PMID:
29380907
6.

Cryptococcal meningitis in apparently immunocompetent patients: association with idiopathic CD4+ lymphopenia.

Shribman S, Noyce A, Gnanapavan S, Lambourne J, Harrison T, Schon F.

Pract Neurol. 2018 Apr;18(2):166-169. doi: 10.1136/practneurol-2017-001800. Epub 2017 Dec 9.

PMID:
29223998
7.

The BRAIN test: a keyboard-tapping test to assess disability and clinical features of multiple sclerosis.

Shribman S, Hasan H, Hadavi S, Giovannoni G, Noyce AJ.

J Neurol. 2018 Feb;265(2):285-290. doi: 10.1007/s00415-017-8690-x. Epub 2017 Dec 4.

8.

Observations on a 2-Step Approach to Screening for Parkinson Disease.

Noyce AJ, Lees A.

JAMA Neurol. 2017 Dec 1;74(12):1506. doi: 10.1001/jamaneurol.2017.3202. No abstract available.

PMID:
29114724
9.

Lupus myelopathy.

Raciborska DD, Noyce AJ, Pyne D, Turner BP.

Pract Neurol. 2018 Feb;18(1):66-69. doi: 10.1136/practneurol-2017-001756. Epub 2017 Nov 2.

PMID:
29097555
10.

Nonsyndromic Parkinson disease in a family with autosomal dominant optic atrophy due to OPA1 mutations.

Lynch DS, Loh SHY, Harley J, Noyce AJ, Martins LM, Wood NW, Houlden H, Plun-Favreau H.

Neurol Genet. 2017 Sep 22;3(5):e188. doi: 10.1212/NXG.0000000000000188. eCollection 2017 Oct. No abstract available.

11.

Sensory-Biased and Multiple-Demand Processing in Human Lateral Frontal Cortex.

Noyce AL, Cestero N, Michalka SW, Shinn-Cunningham BG, Somers DC.

J Neurosci. 2017 Sep 6;37(36):8755-8766. doi: 10.1523/JNEUROSCI.0660-17.2017. Epub 2017 Aug 8.

12.

Parkinson's Disease: Basic Pathomechanisms and a Clinical Overview.

Noyce A, Bandopadhyay R.

Adv Neurobiol. 2017;15:55-92. doi: 10.1007/978-3-319-57193-5_3.

PMID:
28674978
13.

Estimating the causal influence of body mass index on risk of Parkinson disease: A Mendelian randomisation study.

Noyce AJ, Kia DA, Hemani G, Nicolas A, Price TR, De Pablo-Fernandez E, Haycock PC, Lewis PA, Foltynie T, Davey Smith G; International Parkinson Disease Genomics Consortium, Schrag A, Lees AJ, Hardy J, Singleton A, Nalls MA, Pearce N, Lawlor DA, Wood NW.

PLoS Med. 2017 Jun 13;14(6):e1002314. doi: 10.1371/journal.pmed.1002314. eCollection 2017 Jun.

14.

Viral hepatitis and Parkinson disease: A national record-linkage study.

Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Schrag A, Lees A, Goldacre M.

Neurology. 2017 Apr 25;88(17):1630-1633. doi: 10.1212/WNL.0000000000003848. Epub 2017 Mar 29.

PMID:
28356465
15.

Technologies Assessing Limb Bradykinesia in Parkinson's Disease.

Hasan H, Athauda DS, Foltynie T, Noyce AJ.

J Parkinsons Dis. 2017;7(1):65-77. doi: 10.3233/JPD-160878. Review.

16.

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.

Magdalinou NK, Noyce AJ, Pinto R, Lindstrom E, Holmén-Larsson J, Holtta M, Blennow K, Morris HR, Skillbäck T, Warner TT, Lees AJ, Pike I, Ward M, Zetterberg H, Gobom J.

Parkinsonism Relat Disord. 2017 Apr;37:65-71. doi: 10.1016/j.parkreldis.2017.01.016. Epub 2017 Jan 31.

PMID:
28214264
17.

PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease.

Noyce AJ, R'Bibo L, Peress L, Bestwick JP, Adams-Carr KL, Mencacci NE, Hawkes CH, Masters JM, Wood N, Hardy J, Giovannoni G, Lees AJ, Schrag A.

Mov Disord. 2017 Feb;32(2):219-226. doi: 10.1002/mds.26898. Epub 2017 Jan 16.

18.

Subtle motor disturbances in PREDICT-PD participants.

Noyce AJ, Schrag A, Masters JM, Bestwick JP, Giovannoni G, Lees AJ.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):212-217. doi: 10.1136/jnnp-2016-314524. Epub 2016 Dec 16.

19.

Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.

Lubbe SJ, Escott-Price V, Gibbs JR, Nalls MA, Bras J, Price TR, Nicolas A, Jansen IE, Mok KY, Pittman AM, Tomkins JE, Lewis PA, Noyce AJ, Lesage S, Sharma M, Schiff ER, Levine AP, Brice A, Gasser T, Hardy J, Heutink P, Wood NW, Singleton AB, Williams NM, Morris HR; for International Parkinson’s Disease Genomics Consortium.

Hum Mol Genet. 2016 Dec 15;25(24):5483-5489. doi: 10.1093/hmg/ddw348.

20.

Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.

Mok KY, Sheerin U, Simón-Sánchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM, Noyce AJ, Mencacci NE, Lubbe SJ; International Parkinson's Disease Genomics Consortium (IPDGC), Williams-Gray CH, Barker RA, van Dijk KD, Berendse HW, Heutink P, Corvol JC, Cormier F, Lesage S, Brice A, Brockmann K, Schulte C, Gasser T, Foltynie T, Limousin P, Morrison KE, Clarke CE, Sawcer S, Warner TT, Lees AJ, Morris HR, Nalls MA, Singleton AB, Hardy J, Abramov AY, Plagnol V, Williams NM, Wood NW.

Lancet Neurol. 2016 May;15(6):585-96. doi: 10.1016/S1474-4422(16)00071-5. Epub 2016 Mar 24.

21.

Challenges of modifying disease progression in prediagnostic Parkinson's disease.

Salat D, Noyce AJ, Schrag A, Tolosa E.

Lancet Neurol. 2016 May;15(6):637-48. doi: 10.1016/S1474-4422(16)00060-0. Epub 2016 Mar 16. Review.

PMID:
26993435
22.

The prediagnostic phase of Parkinson's disease.

Noyce AJ, Lees AJ, Schrag AE.

J Neurol Neurosurg Psychiatry. 2016 Aug;87(8):871-8. doi: 10.1136/jnnp-2015-311890. Epub 2016 Jan 11. Review.

23.

Short-term memory stores organized by information domain.

Noyce AL, Cestero N, Shinn-Cunningham BG, Somers DC.

Atten Percept Psychophys. 2016 Apr;78(3):960-70. doi: 10.3758/s13414-015-1056-5.

24.

Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?

Noyce AJ, Nalls MA.

Mov Disord. 2016 Apr;31(4):478-83. doi: 10.1002/mds.26492. Epub 2015 Dec 23. Review.

25.

Systematic review and meta-analysis of salivary protein concentration in Parkinson's disease.

Masters JM, Bestwick J, Warner TT, Giovannoni G, Proctor GB, Noyce AJ.

Mov Disord. 2015 Dec;30(14):1971-2. doi: 10.1002/mds.26462. Epub 2015 Nov 19. Review. No abstract available.

PMID:
26583568
26.

Constipation preceding Parkinson's disease: a systematic review and meta-analysis.

Adams-Carr KL, Bestwick JP, Shribman S, Lees A, Schrag A, Noyce AJ.

J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):710-6. doi: 10.1136/jnnp-2015-311680. Epub 2015 Sep 7. Review.

PMID:
26345189
27.

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

Nalls MA, McLean CY, Rick J, Eberly S, Hutten SJ, Gwinn K, Sutherland M, Martinez M, Heutink P, Williams NM, Hardy J, Gasser T, Brice A, Price TR, Nicolas A, Keller MF, Molony C, Gibbs JR, Chen-Plotkin A, Suh E, Letson C, Fiandaca MS, Mapstone M, Federoff HJ, Noyce AJ, Morris H, Van Deerlin VM, Weintraub D, Zabetian C, Hernandez DG, Lesage S, Mullins M, Conley ED, Northover CA, Frasier M, Marek K, Day-Williams AG, Stone DJ, Ioannidis JP, Singleton AB; Parkinson's Disease Biomarkers Program and Parkinson's Progression Marker Initiative investigators.

Lancet Neurol. 2015 Oct;14(10):1002-9. doi: 10.1016/S1474-4422(15)00178-7. Epub 2015 Aug 10.

28.

Elevated salivary protein in Parkinson's disease and salivary DJ-1 as a potential marker of disease severity.

Masters JM, Noyce AJ, Warner TT, Giovannoni G, Proctor GB.

Parkinsonism Relat Disord. 2015 Oct;21(10):1251-5. doi: 10.1016/j.parkreldis.2015.07.021. Epub 2015 Jul 23.

PMID:
26231472
29.

Web-based assessment of Parkinson's prodromal markers identifies GBA variants.

Noyce AJ, Mencacci NE, Schrag A, Bestwick JP, Giovannoni G, Lees AJ, Hardy J.

Mov Disord. 2015 Jun;30(7):1002-3. doi: 10.1002/mds.26249. Epub 2015 May 13. No abstract available.

PMID:
25970725
30.

Oddball distractors demand attention: neural and behavioral responses to predictability in the flanker task.

Noyce A, Sekuler R.

Neuropsychologia. 2014 Dec;65:18-24. doi: 10.1016/j.neuropsychologia.2014.10.002. Epub 2014 Oct 14.

31.

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study.

Schrag A, Horsfall L, Walters K, Noyce A, Petersen I.

Lancet Neurol. 2015 Jan;14(1):57-64. doi: 10.1016/S1474-4422(14)70287-X. Epub 2014 Nov 27.

32.

Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.

Mencacci NE, Isaias IU, Reich MM, Ganos C, Plagnol V, Polke JM, Bras J, Hersheson J, Stamelou M, Pittman AM, Noyce AJ, Mok KY, Opladen T, Kunstmann E, Hodecker S, Münchau A, Volkmann J, Samnick S, Sidle K, Nanji T, Sweeney MG, Houlden H, Batla A, Zecchinelli AL, Pezzoli G, Marotta G, Lees A, Alegria P, Krack P, Cormier-Dequaire F, Lesage S, Brice A, Heutink P, Gasser T, Lubbe SJ, Morris HR, Taba P, Koks S, Majounie E, Raphael Gibbs J, Singleton A, Hardy J, Klebe S, Bhatia KP, Wood NW; International Parkinson’s Disease Genomics Consortium and UCL-exomes consortium.

Brain. 2014 Sep;137(Pt 9):2480-92. doi: 10.1093/brain/awu179. Epub 2014 Jul 2.

33.

Violations of newly-learned predictions elicit two distinct P3 components.

Noyce A, Sekuler R.

Front Hum Neurosci. 2014 Jun 10;8:374. doi: 10.3389/fnhum.2014.00374. eCollection 2014.

34.

Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function.

Noyce AJ, Nagy A, Acharya S, Hadavi S, Bestwick JP, Fearnley J, Lees AJ, Giovannoni G.

PLoS One. 2014 Apr 29;9(4):e96260. doi: 10.1371/journal.pone.0096260. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105488.

35.

A service development study of the assessment and management of fracture risk in Parkinson's disease.

Shribman S, Torsney KM, Noyce AJ, Giovannoni G, Fearnley J, Dobson R.

J Neurol. 2014 Jun;261(6):1153-9. doi: 10.1007/s00415-014-7333-8. Epub 2014 Apr 10.

36.

Bone health in Parkinson's disease: a systematic review and meta-analysis.

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1159-66. doi: 10.1136/jnnp-2013-307307. Epub 2014 Mar 11. Review.

37.

Rapid-onset flaccid paraplegia caused by multiple myeloma dumbbell tumour.

Osborne C, Stallworthy S, Evanson J, Sylvester R, Noyce AJ.

Pract Neurol. 2014 Aug;14(4):268-9. doi: 10.1136/practneurol-2013-000767. Epub 2014 Jan 3. No abstract available.

PMID:
24390704
38.

Mspire-Simulator: LC-MS shotgun proteomic simulator for creating realistic gold standard data.

Noyce AB, Smith R, Dalgleish J, Taylor RM, Erb KC, Okuda N, Prince JT.

J Proteome Res. 2013 Dec 6;12(12):5742-9. doi: 10.1021/pr400727e. Epub 2013 Oct 3.

PMID:
24090032
39.

Genetic comorbidities in Parkinson's disease.

Nalls MA, Saad M, Noyce AJ, Keller MF, Schrag A, Bestwick JP, Traynor BJ, Gibbs JR, Hernandez DG, Cookson MR, Morris HR, Williams N, Gasser T, Heutink P, Wood N, Hardy J, Martinez M, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2); North American Brain Expression Consortium (NABEC); United Kingdom Brain Expression Consortium (UKBEC).

Hum Mol Genet. 2014 Feb 1;23(3):831-41. doi: 10.1093/hmg/ddt465. Epub 2013 Sep 20.

40.

Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.

Djamshidian A, O'Sullivan SS, Foltynie T, Aviles-Olmos I, Limousin P, Noyce A, Zrinzo L, Lees AJ, Averbeck BB.

J Parkinsons Dis. 2013;3(2):139-44. doi: 10.3233/JPD-130178.

41.

PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline results.

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles CH, Hardy J, Giovannoni G, Nageshwaran S, Osborne C, Lees AJ, Schrag A.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):31-7. doi: 10.1136/jnnp-2013-305420. Epub 2013 Jul 4.

42.

Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.

Dobson R, Yarnall A, Noyce AJ, Giovannoni G.

Pract Neurol. 2013 Apr;13(2):70-9. doi: 10.1136/practneurol-2012-000435. Review.

PMID:
23468558
43.

Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A.

Ann Neurol. 2012 Dec;72(6):893-901. doi: 10.1002/ana.23687. Epub 2012 Oct 15. Review.

44.

Distinct endothelial pathways underlie sexual dimorphism in vascular auto-regulation.

Chan MV, Bubb KJ, Noyce A, Villar IC, Duchene J, Hobbs AJ, Scotland RS, Ahluwalia A.

Br J Pharmacol. 2012 Oct;167(4):805-17. doi: 10.1111/j.1476-5381.2012.02012.x.

45.

The new Bradykinesia Akinesia Incoordination (BRAIN) test: preliminary data from an online test of upper limb movement.

Noyce AJ, Treacy C, Budu C, Fearnley J, Lees AJ, Giovannoni G.

Mov Disord. 2012 Jan;27(1):157-8. doi: 10.1002/mds.23947. Epub 2011 Aug 24. No abstract available.

PMID:
22252894
46.

Severe dysphagia as a presentation of Parkinson's disease.

Noyce AJ, Silveira-Moriyama L, Gilpin P, Ling H, Howard R, Lees AJ.

Mov Disord. 2012 Mar;27(3):457-8. doi: 10.1002/mds.24006. Epub 2011 Dec 9. No abstract available.

PMID:
22161964
47.

Stiff person syndrome.

Hadavi S, Noyce AJ, Leslie RD, Giovannoni G.

Pract Neurol. 2011 Oct;11(5):272-82. doi: 10.1136/practneurol-2011-000071. Review.

PMID:
21921002
48.

Familial camptocormia: from dystonia to myopathy.

Doherty KM, Noyce AJ, Silveira-Moriyama L, Nisbet A, Quinn N, Lees AJ.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):350-1. doi: 10.1136/jnnp.2011.246561. Epub 2011 Jul 15. No abstract available.

PMID:
21764889
49.

Eye movements and imitation learning: intentional disruption of expectation.

Maryott J, Noyce A, Sekuler R.

J Vis. 2011 Jan 6;11(1):7. doi: 10.1167/11.1.7.

50.

Teaching NeuroImages: microhemorrhages resulting from cranial radiotherapy in childhood.

Noyce AJ, McCrae S, Gawler J, Evanson J.

Neurology. 2010 Jul 6;75(1):e2-3. doi: 10.1212/WNL.0b013e3181e620df. No abstract available.

PMID:
20603477

Supplemental Content

Support Center